Breast cancer in Egypt: A review of disease presentation and detection strategies

Eastern Mediterranean Health Journal

Volumn 9, Issue 3, 2003, Pages 448-463

  Omar, S ^a   Khaled, H ^a   Gaafar, R ^a   Zekry, A R ^a   Eissa, S ^a   El Khatib, O ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b WHO Regional Office for the Eastern Mediterranean   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CALCITONIN; CARBOPLATIN; CREATINE KINASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIRUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; FLUOROURACIL; HORMONE RECEPTOR; IFOSFAMIDE; ISOENZYME; MELPHALAN; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NAVELBINE; PACLITAXEL; PAMIDRONIC ACID; PREDNISONE; PROGESTERONE RECEPTOR; PROTEIN C; PROTEIN S; PROTHROMBIN; TAMOXIFEN; THROMBOPLASTIN; TROPONIN I; UNINDEXED DRUG; VINCRISTINE; DNA BINDING PROTEIN; MSH2 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN MSH2;

ADVANCED CANCER; AUTOLOGOUS STEM CELL TRANSPLANTATION; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOMYOPATHY; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIARRHEA; EARLY DIAGNOSIS; EGYPT; FEMALE; GASTROINTESTINAL SYMPTOM; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HYPOCALCEMIA; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; MUCOSA INFLAMMATION; ONSET AGE; PREDICTION; PREMENOPAUSE; PREVALENCE; PROGNOSIS; REVIEW; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; THROMBOSIS; VOMITING; AGE DISTRIBUTION; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PREDICTION AND FORECASTING; PRIMARY PREVENTION; PROTO ONCOGENE; SEX RATIO; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

AGE DISTRIBUTION; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DNA-BINDING PROTEINS; EGYPT; FEMALE; GENES, ERBB-2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHATIC METASTASIS; MALE; MASS SCREENING; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; PREVALENCE; PRIMARY PREVENTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEX DISTRIBUTION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 17144402210     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Ries LAG et al. SEER cancer statistics review, 1973-1997 Bethesda, Maryland, National Cancer Institute, 1999.
2. Elatar I. Cancer registration, NCI Egypt 2001. Cairo, Egypt, National Cancer Institute, 2002 (http://www.nci.edu.eg/Journal/nci2001%20.pdf, accessed 1 April 2004).
3. Ibrahim AS et al. Cancer profile in Gharbiah, Egypt. Methodology and results. Cairo, Ministry of Health and Population Egypt and Middle East Cancer Consortium, 2002.
4. Abdel-Wahab AA. Frequent allelic losses at the short arm of chromosome 3p in invasive ductal carcinoma of breast in Egypt. Journal of the Egyptian National Cancer Institute, 2000, 12(2):145-50.
5. Zekri AR et al. Allelic instability as a predictor of survival in Egyptian breast cancer patients. International journal of oncology, 1999, 15:757-67.
6. Bahnassi A et al. The role of allelic imbalance at chromosome 2p16 in breast cancer progression. Journal of Egyptian National Cancer Institute, 2000, 12:211-20.
7. Mansour OA et al. Tissue and serum c-ErbB-2 and tissue EGFR in breast carcinoma: three years follow-up. Anticancer research, 1997, 17:3101-6.
8. Mansour OA et al. Epidermal growth factor receptors: status and effect on breast cancer patients. Anticancer research, 1997, 17:3107-10.
9. El-Bolkainy MN. Topographic pathology of cancer, 2nd ed. Cairo, National Cancer Institute, Cairo University, 2000:87.
10. Mokhtar N. Cancer pathology registry. Cairo, Department of Pathology, National Cancer Institute, 1991.
11. El-Gemeie E, El-Didi M, Nouh A. Fine needle aspiration of breast lesions: the experience of the Egyptian National Cancer Institute. Journal of the Egyptian National Cancer Institute, 1997, 9(3): 239-46.
12. Salih AM, El-Morsy B, Mohamed NH. Cytopathological diagnosis of breast lesions among Egyptians by fine needle sampling without aspiration: using only the needle. Journal of the Egyptian National Cancer Institute, 1996, 8(2):203-11.
13. El-Badawi M, Zaki I, Tantawi S. Magnetic response mammography: diagnostic potentials in breast cancer. Journal of the Egyptian National Cancer Institute, 1999, 11(1):91-8.
14. Ali R, Zedan A. Differentiation between malignant and benign breast lesions using technetium-99m sestamibi. Journal of the Egyptian National Cancer Institute, 1996, 8(2):225-9.
15. Saber RA. Assessment of breast carcinoma by 99mTc-sestamibi scintimammography: effect of lesion site, size and histopathological characteristics. Journal of the Egyptian National Cancer Institute, 2000, 12:183-9.
16. Omar S, Contesso G, Khaled H. Breast cancer, 4th ed. Cairo, National Cancer Institute, Cairo University, 2001.
17. El-Naggar MH et al. Determinants of recurrence after conservative treatment of breast cancer. Journal of the Egyptian National Cancer Institute, 1999, 11(2): 99-108.
18. Abdalla H et al. Detection of local recurrence after breast conserving therapy. Journal of the Egyptian National Cancer Institute 2001, 13(2):93-9.
19. Zaghloul AS et al. Pattern of axillary lymph node metastasis from breast cancer in Egyptian patients. Journal of the Egyptian National Cancer Institute, 2001, 13(1):1-8.
20. Gad-El-Mawla N et al. Adjuvant chemotherapy of primary breast cancer: single agent versus combination chemotherapy. The Egyptian experience. Journal of the Egyptian National Cancer Institute, 1993, 6:225-32.
21. Youssef A et al. Five year results of adjuvant CMF and postoperative radiotherapy in node positive premenopausal women with operable breast cancer randomization in timing of chemotherapy. Journal of the Egyptian National Cancer Institute, 1995, 7(1):61-5.
22. Youssef A et al. Concomitant adjuvant epirubicin containing chemotherapy and postoperative radiotherapy in premenopausal patients with respectable breast carcinoma and more than three positive axillary nodes: A pilot study. Journal of the Egyptian National Cancer Institute, 1995, 7(2):169-74.
23. Haybittle JL et al. A prognostic index in primary breat cancer. British journal of cancer, 1982, 45:361-6.
24. El-Mongy M et al. Prognostic index in breast cancer: evaluation and correlation with treatment results. Journal of the Egyptian National Cancer Institute, 1997, 9(3):191-9.
25. El-Gantiry M. Breast carcinoma in 1208 premenopausal Egyptian patients: Treatment results at fifteen years with emphasis on age as a prognostic factor. Journal of the Egyptian National Cancer Institute 1997, 9(1):1-10.
26. Abu Rabia A, Helal M, Mohamed NH. Ultrasonographic appearance of the endometrium in postmenopausal breast cancer patients on long-term tamoxifen therapy. Journal of the Egyptian National Cancer Institute 1999, 11(2):189-95.
27. Sedky L et al. The value of troponin measurement in assessment of anthracycline induced cardiotoxicity in breast cancer patients. Journal of the Egyptian National Cancer Institute, 2000, 12(1): 35-40.
28. Abou Taleb FM, El-Nemr NM, al-Husseiny H. Thrombogenesis in patients with breast cancer treated with adjuvant CMF protocol. Journal of the Egyptian National Cancer Institute, 2000, 12(2): 125-9.
29. Van der Hage JA et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer, trial 10902. Journal of clinical oncology, 2001, 19(22):4224-37.
30. El-Noweim SA et al. Combined modality approach of locally advanced breast cancer with conservative surgery. Journal of the Egyptian National Cancer Institute, 1995, 7(1):123-30.
31. Richards MA et al. Advanced breast cancer in Egyptian women: clinical features and response to endocrine therapy. European journal of surgical oncology, 1992, 18:219-23.
32. Gad El-Mawla N et al. Ifosfamide, methotrexate and 5-fluorouracil: effective combination in resistant breast cancer. Cancer chemotherapy and pharmacology, 1999, 26(suppl.):S85-6.
33. Gad El-Mawla N et al. A phase II study of epirubicin in breast cancer. Anti-cancer drugs, 1991, 2:371-4.
34. Osman I, El-Hattab O. Phase II study of Vinorelbine (Navelbine) with 5-fluorouracil infusion in metastatic infusion in metastatic and recurrent breast cancer. Journal of the Egyptian National Cancer Institute, 1997, 9(2):127-31.
35. Ali NM, El-Hattab O. Paclitaxel plus doxorubicin combination as first line treatment in metastatic breast cancer patients: comparison with fluoruocil, doxorubicin and cyclophosphamide regimen (a single blind randomized clinical trial). Journal of the Egyptian National Cancer Institute, 1999, 11(2): 151-6.
36. El-Wasseef MM et al. Pamidronate dosodium versus calcitonin: a comparative study in the management of malignant bone pain in metastatic breast cancer patients. Journal of the Egyptian National Cancer Institute, 2001, 13(2):109-15.
37. Naguib SF. Salvage surgery for recurrent and locally advanced breast cancer. Journal of the Egyptian National Cancer Institute, 1999, 11(3):197-203.
38. Gaafar R et al. Prognostic significance of epidermal growth factor receptor and estrogen receptor in advanced breast cancer. Journal of the Egyptian National Cancer Institute, 1996, 8(2):231-9.
39. Hashem T et al. The correlation between erythrocyte glutathione level and thyroid hormones levels in blood and response to chemotherapy in patients with advanced breast cancer. Journal of the Egyptian National Cancer Institute, 1996, 8(1):39-44.
40. Shouman SA, Saber MM, El-Marzabany M. The potential value of serum osteocalcin in patients with metastatic breast cancer. Journal of the Egyptian National Cancer Institute, 1995, 7(2):199-205.
41. Omar S et al. End result of breast cancer therapy. II. Clinical immunological and hormonal profile of inflammatory carcinoma of the breast. A: Clinicopathological aspects. Cancer prevention and therapy, 1989, 1:29-41.
42. Seif NY, Aziz MA. Effect of breast self-examination training programme on knowledge, attitude and practice of a group of working women. Journal of the Egyptian National Cancer Institute, 2000, 12(2):105-15.
43. Naguib S et al. Mammographic wire localization for non-palpable breast cancer. Journal of the Egyptian National Cancer Institute, 1999, 11(1):1-8.
44. Hafez MH, Selim A. Accuracy of stereostatic core biopsy for non-palpable breast lesion. Journal of the Egyptian National Cancer Institute, 1998, 10(3): 333-9.